BNP Paribas Financial Markets’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,125,000
Closed -$8.85M 4765
2022
Q3
$8.85M Buy
+1,125,000
New +$11M 0.01% 1039

Other funds holding AONC

BNP Paribas Financial Markets's AONC Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q4 2022, closing a stake of 1,125,000 shares — an estimated $8.85M sold.

BNP Paribas Financial Markets first reported a position in AONC in Q3 2022 and held it in 1 quarter. The position peaked at $8.85M in Q3 2022. 79 funds tracked by Wall St. Rank hold AONC as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,125,000 American Oncology Network, Inc. Class A Common Stock shares in Q4 2022, an estimated $8.85M.
  • BNP Paribas Financial Markets first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2022 and held it in 1 quarter.
  • BNP Paribas Financial Markets's American Oncology Network, Inc. Class A Common Stock position peaked at $8.85M in Q3 2022.
  • 79 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.